SYDNEY, AUSTRALIA and LISLE, IL--(MARKET WIRE)--Jul 19, 2007 -- AtCor Medical Holdings Limited (ASX:ACG.AX - News), the developer and marketer of the SphygmoCor® system, which non-invasively measures central blood pressures, today announced that it has signed agreements with three leading international pharmaceutical companies to supply SphygmoCor systems and clinical trial support services for new and ongoing drug trials in Europe and the United States. The total value of the contracts is approximately US $1.8 million.
